simendan has been researched along with Angor Pectoris in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Santis, V; Morelli, A; Nofroni, I; Pietropaoli, P; Puddu, PE; Santulli, M; Singer, M; Tritapepe, L; Vitale, D | 1 |
| Baldassarri, R; Cariello, C; Danella, A; Doroni, L; Guarracino, F; Lapolla, F; Stefani, M; Vullo, C | 1 |
1 trial(s) available for simendan and Angor Pectoris
| Article | Year |
|---|---|
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study.
Topics: Aged; Angina Pectoris; Biomarkers; Cardiotonic Agents; Coronary Artery Bypass; Double-Blind Method; Female; Hemodynamics; Humans; Hydrazones; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Myocardial Reperfusion Injury; Pilot Projects; Preoperative Care; Pyridazines; Simendan; Troponin I | 2006 |
1 other study(ies) available for simendan and Angor Pectoris
| Article | Year |
|---|---|
Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Female; Heart Rate; Humans; Hydrazones; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Vascular Resistance; Ventricular Dysfunction, Left; Ventricular Function, Left | 2007 |